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Abstract
Various intractable diseases have been cured by the development of many newmedicines.
However, cancer is still a major cause of death. We focused on β-glucan which heat treated
Enterococcus faecalis in human intestine, and investigated antioxidant activity, antitumor
activity, immune response, etc. In this study, we studied the immunostimulatory effect of
β-glucan and its application as a radioprotective agent. As a result, β-D-glucan is known
to possess antioxidant activity. Its action is thought to be due to radical scavenger reaction.
In our study, β-glucan increased the amount of killer cells and suppressor T cells. There-
fore, administration of β-glucan is thought to have an anticancer action. In the future, we
hypothesize that β-glucan could be used as an immunopotentiating agent which is effec-
tive for the prevention of cancer. From now on, further research will be necessary on the
search for cancer cell receptors and to conduct fundamental research on the synergistic
effects of radiation therapy. β-glucan showed strong antitumor activity against two kinds
of solid carcinoma. Taken altogether, this strongly suggests that β-glucan enhances innate
functions of macrophages and NK cells, and as a result, secondarily enhances the immune
reaction and suppresses tumor growth.
Keywords: radioprotection, β-glucan, antitumor activity, immunoresponse, IFN-γ,
NK cells, TNF-α, lymphocytes
1. Introduction
Previously, various intractable diseases have been cured by the development of many new
or alternative medicines approaches. Although there is considerable progress in the devel-
opment of anticancer drugs, cancer is still the leading cause of death in developed coun-
tries. Carcinogenesis induced by various environmental factors has different mechanisms.
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Depending on the type of cancer, the therapeutic effect varies and individual differences
are also variably large. Therefore, early detection, early treatment and early treatment are
urgent [1].
The primary cause of death in Japan is malignant tumors. The incidence of malignant tumors is
increasing year by year and one out of three patients die from malignant tumors [2]. Japanese
longevity is considered a lifestyle such as ingestion of a lot of fish, ingestion of enzyme foodstuffs
and diligence [3, 4]. In any case, malignant tumors have to be destroyed and, at present, there are
three main forms of treatment that directly kill the lesion or malignant cells [5].
These three major forms of therapy have severe mental and physical burdens as well as the
side effects and weakening of the immune system are also serious problems. In addition, there
is no possibility of cessation of treatment, and the motivation for life is also considerably
reduced [6–9].
Therefore, research on treatments that exclude the burden on the body as much as possible,
such as surgery using a robot and immunotherapy, is underway in recent cancer treatment
methods [10, 11].
At the same time, research has also been made to improve disease from the root cause from the
viewpoint of oriental medicine. However, it seems that the three major therapies will continue
to establish immovable status in the treatment of malignant tumors, and side effects caused by
them as well as the reduction of immunity are main problems [3, 12–14].
Radiotherapy is especially important because it is a noninvasive and function-preserving
method. And, if the side effects on normal tissues related to treatment can be overcome, it would
be one of the most important methods in the future. When hematopoietic tissue is affected by
radiation, bacterial and viral infections due to immune system weakness, genetic changes due to
cell necrosis and DNA damage, mutations, and cancer occur as side effects [15–17].
For that reason, various radioprotective agents have also been studied. In fact, a radiation
protection agent called WR-2721 was developed at the Water Reed Army Hospital in the
United States and clinical trials were conducted, but it is no longer commonly used due to side
effects such as vomiting and rash [18–20].
Therefore, it is urgent to develop a radiation protection agent with fewer side effects, and
approaches focusing on natural substances, which are said to have relatively few side
effects.
In recent years, approaches for reducing the side effects of anticancer drugs with natural
substances in Japan and Korea are prosperous, among which propolis is drawing attention as
a natural anticancer agent and an immunopotentiating agent [19, 21].
Various medicinal ingredients and physiological effects have been reported on this sub-
stance. As components thereof, carbohydrates, amino acids, minerals, terpenoids, amino
acids and the like are contained and components contained therein are changed by the
extraction method.
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In the case of general alcohol extraction, numerous lipophilic components such as flavo-
noids, which are said to be effective ingredients, are extracted, but in the case of the water
extraction method devised by Suzuki et al. the levels of flavonoids decrease. However,
there are reports that water extraction has higher antitumor effect than alcohol extraction.
Antitumor effects are reported for β-(1-3) D glucan, β-(1-6) D glucan [22, 23].
Based on the above information, in this study, we examined the protective effect of β-glucan on
lymphocytes exposed to radiation as well as its ability in reducing side effects caused by
radiation therapy [24–27]. In case of radiation therapy, it is applied when the radiation sensi-
tivity is high under the condition that the cancer condition is local.
We also examined the effect on tumor growth when combined with radiation therapy.
Therefore, this study aims to propose β-glucan as the first step as a new radioprotective
agent that can be used at the time of radiotherapy and to contribute data for future
development.
2. Materials and methods
2.1. Animals
Mice were purchased from a Japanese SLC company and adjusted to the experimental condi-
tions of this study for 1 week prior to the start of the experiment. The mouse used in this study
is a male C3H/Hej mouse. In order to synchronize the purchased mouse, the light was adjusted
(12 L:12 D) and kept. Food and water were allowed ad libitum.
2.2. Test material
Enteroccous Faecalis 2001
®, a glucan product, composed of yeast extract, dextrin and gelatin
was supplied by Nihon BRM Co. Ltd. (Tokyo, Japan) and β-1,3 glucan as an active ingredient
was contained at the ratio of 6.5 mg/g of the product. Enteroccous Faecalis 2001® is hereafter
described as β-glucan throughout this paper. Glucan was suspended in physiological saline at
concentrations of 2, 4 and 8% (w/v).
2.3. Radio-protective effect
Each mouse was intraperitoneally injected with β-glucan at a dose of 200, 400, 2800 mg/kg/day
at 1 day intervals for 2 weeks. The sham control group of mice received an equal volume of
normal saline. After the final injection, the mice were irradiated with 2 Gy of X-ray. Whole
body irradiation was performed with a dose of 8 Gy (dose rate 1.12 Gy/min) using an X-ray
irradiation device (MG226/4.5, Phillips, Inc., Tokyo). Body weight and number of surviving
animals were monitored daily.
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2.4. Antitumor effect
SSC-7 carcinoma cells were inoculated subcutaneously (5  105) into the right femur of mice.
After the average long diameter of the tumors reached 5 mm, mice were intraperitoneally injected
with β-glucan suspended in physiological saline at a dose of 200, 400 and 800 mg/kg/day for 5
consecutive days. Control mice received an equal volume of normal saline. At the given time
point, the major and minor axes of the tumor were measured with a caliper and the tumor
volume was calculated by the following equation; V = (pi/6) ab2, a: major axis length, b: minor
axis length.
2.5. Leukocyte and lymphocyte counts
The β-glucan suspended in physiological saline was intraperitoneally injected into mice at
doses of 200, 400, 800 mg/kg. Control mice received an equal volume of normal saline. After
the injection, in order to measure the number of white blood cells and lymphocytes using an
automated hemocytometer (Celltac-α, MEK-6318, Nihon kouden Co. Ltd., Tokyo), a blood
sample was transferred from the tail vein into a heparinized tube.
2.6. NK cell activity
The β-glucan suspended in physiological saline was intraperitoneally injected at a dose of 400
and 800 mg/kg for 2 weeks at intervals of 1 day. Vehicle control mice received an equal volume
of normal saline. Spleen cells were prepared to measure NK cell mediated cytotoxicity by 51C-
release from labeled AC-1 cells (2  104 cells) after the final injection. Briefly, 51Cr labeled
YAC-1 cells (2  104 cells) were added to various dilutions of splenocyte suspensions in flat
bottom microplates. The mixture was incubated for 4 h at 37C in a CO2-incubator. The
radioactivity released to the supernatant was counted with a γ-counter and the magnitude of
cell lysis calculated based on the average radioactivity of the control group was defined as NK
cell activity.
2.7. Statistical analysis
Significance of the difference in each parameter among groups was assessed by Tukey’s
multiple comparison tests following analysis of variance. Values of p < 0.05 were considered
significant.
3. Results
3.1. Radio-protective effect and leukocyte and lymphocyte counts
The survival of irradiated mice is summarized in Figures 1–5. All of the animals in the irradiated
control group died from the 5th day to the 7th day following irradiation. Glucan injected intra-
peritoneally prolonged the survival of mice 80% on the 7th day at the doses of 200 mg/kg.
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The number of leukocytes increased with time at least up to 24 h after each repeated dose of
glucan in a dose-dependent manner. The lymphocyte counts also showed a similar tendency to
increase as in the leukocyte counts.
3.2. Antitumor effect
Figure 6 shows anticancer effect of various β-glucan concentrations. The tumor of the control
group grew with time, whereas glucan injected intraperitoneally made tumor growth delay
significantly in a dose-dependent manner Figure 3.
3.3. NK activity
Figure 7 shows NK activity of various β-glucan concentrations. NK cell activities in mice are
shown in Figure 7. The NK activity increased significantly about twofold to threefold after
each repeated dose of glucan (400 and 800 mg/kg).
3.4. Discussion
In the present study, we have found that β-glucan showed antioxidant activity. Previously,
Ekaterini et al. have reported that β-glucan shows antioxidant activity [28], suggesting that β-
glucan may be responsible for the activity that we found in our study. β-Glucan is well known
for its radioprotective and antitumor effect in vivo [29–32], and these effects were reproduced
in this study.
Figure 1. Leukocyte counts on different days after irradiation in mice of different groups. The number of leukocyte was
calculated from the pre-irradiation values taken as 100%. The bars represent standard deviation. *Statistically significant
(p < 0.05) from the control group.
Radiation Protective and Immunopotentiating Effect of Lymphocytes by β-Glucan
http://dx.doi.org/10.5772/intechopen.80496
105
Figure 2. Lymphocyte counts on different days after irradiation in mice of different groups. The number of lymphocyte
was calculated from the pre-irradiation values taken as 100%. The bars represent standard deviation. *Statistically
significant (p < 0.05) from the control group.
Figure 3. The increased percentage of CD4+, CD8+ and CD16+ T-lymphocytes in PBLs compared to the experimental data
baselines of the groups. The unit is in percentage (%). Significantly different from *p < 0.05 control group vs. β-glucan
groups by Dunnett’s test.
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Figure 4. Survival after irradiation. Surviving fraction was increased after injection of β-glucan.
Figure 5. Radiation protection effect of mucosal damage of small intestine to β-glucan of both doses of 12 and 24 mg/kg
concentration.
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To confirm the elucidation mechanism by which β-glucan exerts these effects, the number of
white blood cells and lymphocytes was monitored as a hematopoietic effect. Furthermore, NK
cell activity was measured as an immunological parameter. The results of these parameters
demonstrated that the radioprotective effect of β-glucan is mediated, at least in part, by
hematopoietic effects in irradiated mice. This is because the leukocyte and lymphocyte counts
Figure 6. Effect of β-glucan on the tumor growth in mice inoculated with SSC-7 carcinoma cells. Groups of 10 mice were
subjected to different treatment. Results represent means  S.D. *Statistically significant (p < 0.05) from the control group.
Figure 7. Repeated dose effect of β-glucan on the NK activity in mice. Groups of 10 mice each were subjected to each
treatment. Results represent means  S.D. *Statistically significant (p < 0.05) from the control group. **Statistically
significant (p < 0.01) from the control group.
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increased with a single administration of β-glucan. In addition, the enhanced immunological
activity as seen by the increase in NK cell activity by β-glucan appears to play a role in the
prevention of secondary infections associated with radiation.
Figure 8. This slide shows a mechanism of radiation protection effect of various β-glucan concentrations.
Figure 9. This slide demonstrates a mechanism of activity of NK and LAK cells of lymphocytes by various β-glucan
concentrations.
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Natural killer (NK) and lymphokine-activated killer (LAK) cells are well known to be associated
with cytotoxic effects on various kinds of tumor cells [33, 34]. The reason why the immature
immune response of young mice was activated to the same level as observed in adult mice is that
the various components in the sample used in this experiment most probably activated IL-2 and
IL-6 of the immune system. IFN-γ, cytokines and the like are multifunctional factors showing
antiviral effect, inhibition of cell proliferation, antitumor effect, macrophage activation, enhance-
ment of NK cell activation, regulation of immune response, and differentiation induction.
Specifically, high levels of IFN-γ were measured in mice bearing the S-180 carcinoma, after
administration of β-glucan [35–38].
IL-4 is mainly associated with a class switch of IgM to IgG. IFN-γ and IL-4 are related to
differentiation of Th1 and TH2, respectively, and these cytokines suppress each other [37–39].
When antitumor action was examined using two kinds of sarcoma (Ehrlich solid carcinoma
and Sarcoma-180 carcinoma), tumor-suppressive ratios after treatment with β-glucan was
83%. When Sarcoma-180 solid carcinoma was used, tumor-suppressive ratios was 60%. Thus,
β-glucan showed strong antitumor activity against two kinds of solid carcinoma [40, 41].
Therefore, there is the possibility that after treatment with β-glucan, in which no antioxidant
activity is found, the balance between NF-κB and I-κB is lost, and the apparent tumor-
suppressive ratio is low due to suppression of apoptosis of tumor cells. Thus, it is possible that
β-glucan restores the balance between NF-κB and I-κB, and induces apoptosis and tumor
suppression secondarily [42].
Figure 10. This slide shows a mechanism of activity of antitumor effect by β-glucan.
Lymphocytes110
Therefore, increased activity of NK by β-glucan contributes most probably to attenuated
tumor growth in tumor-bearing mice. Based on these data, glucan is expected to be a promis-
ing agent for the treatment of cancer patients receiving radiotherapy (Figures 8–10).
4. Conclusion
In this study we have evaluated the anticancer properties of β-glucan using a mouse model. β-
glucan was found to upregulate CD8+ lymphocytes and leukocytes as well as reducing tumor
volume and mass. We believe two phenomena may be correlated but further research is
required to elucidate the exact role of β-glucan. Nonetheless, it may be possible to suggest that
β-glucan could be used as a potential anticancer agent. β-Glucan was also found to improve
recovery rate of lymphocytes and leukocytes following irradiation. We believe this may be due
to antioxidant properties of β-glucan suggesting its possible use as an alternative radioprotec-
tive agent with reduced side effects.
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